OptiBiotix Health (LON:OPTI) Sets New 1-Year Low – What’s Next?

by · The Cerbat Gem

OptiBiotix Health Plc (LON:OPTI – Get Free Report)’s share price hit a new 52-week low on Monday . The company traded as low as GBX 7.16 and last traded at GBX 7.38, with a volume of 278564 shares changing hands. The stock had previously closed at GBX 7.72.

OptiBiotix Health Stock Down 4.4%

The company’s fifty day moving average is GBX 8.67 and its 200-day moving average is GBX 10.57. The company has a market cap of £7.62 million, a PE ratio of -246.00 and a beta of 1.71.

OptiBiotix Health (LON:OPTI – Get Free Report) last announced its earnings results on Tuesday, September 16th. The company reported GBX (1.15) earnings per share for the quarter. OptiBiotix Health had a negative net margin of 524.43% and a negative return on equity of 36.76%.

Insider Activity

In other OptiBiotix Health news, insider Stephen O’Hara acquired 95,238 shares of the stock in a transaction dated Tuesday, September 23rd. The shares were purchased at an average price of GBX 11 per share, for a total transaction of £10,476.18. Also, insider David Blain bought 84,053 shares of the business’s stock in a transaction that occurred on Wednesday, October 1st. The shares were acquired at an average price of GBX 1,175 per share, with a total value of £987,622.75. Insiders acquired 229,291 shares of company stock worth $100,309,893 over the last three months. Insiders own 26.82% of the company’s stock.

OptiBiotix Health Company Profile

(Get Free Report)

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.

Read More